History | Bendamustine for the first-line treatment of chronic lymphocytic leukaemia | Guidance | NICE

History

A list of downloadable documents created during development.

Background information

TA216 Leukaemia (lymphocytic) - bendamustine: review decision - March 2014 information
Appendix A - Decision paper presented to the Institute's Guidance Executive ^{PDF 103 KB} 03 March 2014
TA216 Leukaemia (lymphocytic) - bendamustine: review proposal - December 2013 information
TA216 Leukaemia (lymphocytic) - bendamustine: Appendix A - provisional matrix of stakeholders ^{PDF 100 KB} 20 December 2013
TA216 Leukaemia (lymphocytic) - bendamustine: Appendix B - proposal paper presented to the Institute's Guidance Executive ^{PDF 296 KB} 20 December 2013

Leukaemia (lymphocytic) - bendamustine: equality impact assessment

Leukaemia (lymphocytic) - bendamustine: equality impact assessment ^{PDF 20 KB} 23 February 2011

Leukaemia (lymphocytic) - bendamustine: final appraisal determination

Leukaemia (lymphocytic) - bendamustine: final appraisal determination information
Leukaemia (lymphocytic) - bendamustine: final appraisal determination document ^{PDF 228 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: pre-meeting briefing ^{PDF 252 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: final scope and final matrix of comsultees and commentators
Leukaemia (lymphocytic) - bendamustine: scope ^{PDF 46 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: matrix ^{PDF 55 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: manufacturer submission ^{PDF 3.18 MB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: clarification letters
Leukaemia (lymphocytic) - bendamustine: NICE request to the manufacturer for clarification on their submission ^{PDF 71 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 1 ^{PDF 354 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 2 ^{PDF 36 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: patient group, professional group and NHS organisation submissions
Leukaemia (lymphocytic) - bendamustine: British Society for Haematology and Royal College of Pathologists (joint submission) ^{PDF 223 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Chronic Lymphocytic Leukaemia Support Association ^{PDF 270 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Leukaemia CARE ^{PDF 34 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Lymphoma Association ^{PDF 173 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Royal College of Physicians / NCRI / RCR / ACP / JCCO ^{PDF 95 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: United Kingdom Chronic Lymphocytic Leukaemia Forum ^{PDF 212 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Expert personal perspectives
Leukaemia (lymphocytic) - bendamustine: Jane Barnard nominated ^{PDF 15 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Dr Chris Fegan ^{PDF 16 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Professor Andrew Pettitt ^{PDF 14 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Chonette Taylor ^{PDF 13 KB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Evidence Review Group report ^{PDF 1.63 MB} 23 December 2010
Leukaemia (lymphocytic) - bendamustine: Evidence Review Group report - factual accuracy check ^{PDF 53 KB} 23 December 2010

Leukaemia (lymphocytic) - bendamustine: response to consultee and commentator comments on the draft scope

Leukaemia (lymphocytic) - bendamustine: response to consultee and commentator comments on the draft scope ^{PDF 87 KB} 07 July 2010

Leukaemia (lymphocytic) - bendamustine: institutes response to consultee and commentator comments on the provisional matrix

Leukaemia (lymphocytic) - bendamustine: institutes response to consultee and commentator comments on the provisional matrix ^{PDF 22 KB} 02 July 2010

Leukaemia (lymphocytic) - bendamustine: final matrix

Leukaemia (lymphocytic) - bendamustine: final matrix ^{PDF 31 KB} 02 July 2010

Leukaemia (lymphocytic) - bendamustine: final scope

Leukaemia (lymphocytic) - bendamustine: final scope ^{PDF 26 KB} 02 July 2010

Appendix C - provisional matrix (pre-referral) - November 2009

Appendix C - provisional matrix (pre-referral) - November 2009 ^{PDF 55 KB} 16 April 2010

Appendix B - draft scope for consultation (pre-referral) - November 2009

Appendix B - draft scope for consultation (pre-referral) - November 2009 ^{PDF 47 KB} 16 April 2010